Peptique
About
Listed competitors
Also in this space
Shares AI-Driven Protein Design, Drug Discovery
Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Shares Biotech, HealthTech
AI-driven drug discovery platform accelerating breakthrough scientific research.
Shares Drug Discovery, Generative AI
AI-powered platform for designing novel molecular structures for new medicines.
Shares Biotech, Drug Discovery
AI-driven drug discovery platform for rapid development of novel therapeutics.
Shares Biotech, Drug Discovery
Automated wet lab for AI-driven protein design, enabling rapid synthesis, expression, and testing of thousands of protein designs.
Shares Drug Discovery, Biotech
Key facts
- Website
- peptique.io
- Total funding
- $2M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 1 Jan 2023 | Seed | $2M | The Engine Fund |
Tech stack
Detected on peptique.io, last scanned 31 Oct 2026. Run your own scan
- Analytics
- PostHog
- CDN
- Vercel
Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is Peptique trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Peptique is 58 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Peptique raised?
Peptique has raised a total of $2M in funding. The most recent round on record is Seed.
SEC filings, insider activity, nonprofit links and pay benchmarks for Peptique:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

